SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX, OLO, KLG, GNTY on Behalf of Shareholders - Guaranty Bancshares ( NYSE:GNTY ) , Cargo Therapeutics ( NASDAQ:CRGX )
NEW YORK, July 14, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CARGO Therapeutics, Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CARGO Therapeutics, Inc. ( Nasdaq - CRGX ) , Olo Inc. ( NYSE - OLO ) , WK Kellogg Co ( NYSE - KLG ) , Guaranty Bancshares, Inc. ( NYSE - GNTY )
BALA CYNWYD, Pa., July 14, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, CRGX, HMST, PBBK on Behalf of Shareholders - HomeStreet ( NASDAQ:HMST ) , Cargo Therapeutics ( NASDAQ:CRGX )
NEW YORK, July 12, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Olo Inc.
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CARGO Therapeutics, Inc. ( NASDAQ: CRGX )
NEW YORK, July 09, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX and WNS on Behalf of Shareholders - WNS ( Holdings ) ( NYSE:WNS ) , Cargo Therapeutics ( NASDAQ:CRGX )
NEW YORK, July 09, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CARGO Therapeutics, Inc.
Why CARGO Therapeutics Stock Is Gaining Today - Cargo Therapeutics ( NASDAQ:CRGX )
Concentra to acquire CARGO for $4.379 per share plus CVRs. Shareholders may get extra proceeds from asset sales post-merger. From tariffs to inflation, macro risks are rising-Matt Maley reveals how he's trading it all, live this Wednesday July 9 at 6 PM ET. CARGO Therapeutics Inc.
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right
SAN CARLOS, Calif., July 08, 2025 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. ( "CARGO" or the "Company" ) ( NASDAQ: CRGX ) , a biotechnology company that has focused on developing CAR T-cell therapies, today announced that it has entered into a definitive merger agreement ( the "Merger ...
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right - Cargo Therapeutics ( NASDAQ:CRGX )
SAN CARLOS, Calif., July 08, 2025 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. ( "CARGO" or the "Company" ) CRGX, a biotechnology company that has focused on developing CAR T-cell therapies, today announced that it has entered into a definitive merger agreement ( the "Merger Agreement" ) with ...
Crescent Biopharma Appoints David Lubner to Board of Directors - GlycoMimetics ( NASDAQ:GLYC )
Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations
CARGO Therapeutics Provides Corporate Update - Cargo Therapeutics ( NASDAQ:CRGX )
- Development of CRG-023 and allogeneic platform suspended; further reduction in force ( RIF ) of approximately 90% to preserve cash and maximize shareholder value - - CARGO had cash, cash equivalents and marketable securities of $368.1 million as of December 31, 2024 -
After Plunging -69.58% in 4 Weeks, Here's Why the Trend Might Reverse for CARGO Therapeutics, Inc. ( CRGX )
CARGO Therapeutics, Inc. (CRGX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in ...
Here's Why CARGO Therapeutics, Inc. ( CRGX ) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for CARGO Therapeutics, Inc. (CRGX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
CARGO Therapeutics, Inc. ( CRGX ) Upgraded to Buy: What Does It Mean for the Stock?
CARGO Therapeutics, Inc. (CRGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Nasdaq Moves Lower; Meta Platforms Posts Strong Sales - Alterity Therapeutics ( NASDAQ:ATHE ) , Cargo Therapeutics ( NASDAQ:CRGX )
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.18% to 44,795.97 while the NASDAQ fell 0.25% to 19,583.83. The S&P 500 also rose, gaining, 0.10% to 6,045.09. Communication services shares surged by 1.9% on Thursday.
Dow Jumps Over 100 Points; Tesla Earnings Miss Views - Alterity Therapeutics ( NASDAQ:ATHE ) , Alpha Modus Holdings ( NASDAQ:AMOD )
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. The Dow traded up 0.26% to 44,829.59 while the NASDAQ gained 0.75% to 19,779.27. The S&P 500 also rose, gaining, 0.63% to 6,077.45. Communication services shares surged by 2.4% on Thursday.
This Everest Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Everest Group ( NYSE:EG ) , Cargo Therapeutics ( NASDAQ:CRGX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Kate McShane downgraded the rating for Floor & Decor Holdings, Inc.
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025 - Cargo Therapeutics ( NASDAQ:CRGX )
- 71 patients dosed in the potentially pivotal Phase 2 clinical study of firicabtagene autoleucel ( firi-cel ) ; Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023, CARGO's tri-specific CAR T, cleared by the FDA.
Axsome Therapeutics, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Arqit Quantum ( NASDAQ:ARQQ ) , Axsome Therapeutics ( NASDAQ:AXSM )
U.S. stock futures were lower this morning, with the Dow futures falling more than 50 points on Monday. Shares of Axsome Therapeutics, Inc. AXSM fell sharply in today's pre-market trading after the announced completion and results of Phase 3 clinical program of AXS-05 in Alzheimer's Disease ...
Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. ( CRGX ) Looks Ripe for a Turnaround
CARGO Therapeutics, Inc. (CRGX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Bears are Losing Control Over CARGO Therapeutics, Inc. ( CRGX ) , Here's Why It's a 'Buy' Now
CARGO Therapeutics, Inc. (CRGX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
CARGO Therapeutics to Participate in Upcoming Investor Conferences - Cargo Therapeutics ( NASDAQ:CRGX )
SAN CARLOS, Calif., Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. CRGX, a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will be participating in the following ...
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity - Cargo Therapeutics ( NASDAQ:CRGX )
- CRG-023 is a CD19-, CD20-, CD22-targeting tri-specific CAR T product candidate designed with the goal of providing more patients with a broad range of B-cell malignancies with durable responses by addressing several known causes of relapse, resulting in a potential best-in-class CAR T-cell ...
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma ...
Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week
Along with quarterly results, the clinical-stage company provided an encouraging business update.
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying - Wintrust Finl ( NASDAQ:WTFC )
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
CARGO Therapeutics to Participate in Upcoming Investor Conferences - Cargo Therapeutics ( NASDAQ:CRGX )
SAN CARLOS, Calif., May 28, 2024 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. CRGX, a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will be participating in the following ...
CARGO Therapeutics to Participate in Upcoming Investor Conferences
SAN CARLOS, Calif., May 28, 2024 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. ( NASDAQ: CRGX ) , a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will be participating in the ...
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing - Cargo Therapeutics ( NASDAQ:CRGX )
- Financing includes participation from new and existing investors - - Supports BLA preparation for potentially pivotal Phase 2 study, FIRCE-1 of firicabtagene autoleucel ( firi-cel ) ( CRG-022 ) and IND-enabling studies for CRG-023 -
What Makes CARGO Therapeutics, Inc. ( CRGX ) a New Buy Stock
CARGO Therapeutics, Inc. (CRGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. ( CRGX ) : Can the Stock Really Move This High?
The consensus price target hints at a 56.3% upside potential for CARGO Therapeutics, Inc. (CRGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors - Cargo Therapeutics ( NASDAQ:CRGX )
SAN MATEO, Calif., April 15, 2024 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. CRGX, a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced it has appointed Kapil Dhingra, M.B.B.S., to the Company's ...
Company News for Mar 25, 2024
Companies in The News ...
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
CARGO Therapeutics today provided a business update and reported financial results for the quarter and year ending December 31, 2023.
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Science Applications Intl ( NASDAQ:SAIC )
Shares of Science Applications International Corporation SAIC fell sharply during Monday's session after the company reported financial fourth-quarter EPS below estimates. SAIC reported a 12% revenue decline Y/Y in the fourth quarter of fiscal 2024 to $1.74 billion, beating the consensus of $1.64 ...
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday - Alta Equipment Group ( NYSE:ALTG ) , Despegar.com ( NYSE:DESP ) , Blend Labs ( NYSE:BLND )
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. BLND rose sharply during Friday's session after the company reported fourth-quarter financial results. Blend Labs posted quarterly loss of 9 cents per share, in-line with market ...
Nested Therapeutics Strengthens Board of Directors with Appointment of New Chair and Directors
CAMBRIDGE, Mass., Feb. 27, 2024 /PRNewswire/ -- Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced the appointment of three members to its board of directors: John A.
Alexandria ( ARE ) to Post Q4 Earnings: What's in the Cards?
While Alexandria's (ARE) Q4 earnings are likely to have benefited from the healthy demand for its high-quality life science and lab office properties, high-interest expenses and economic uncertainty raise concern.
Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday - Axogen ( NASDAQ:AXGN ) , Bridger Aerospace Gr ( NASDAQ:BAER )
U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of The Greenbrier Companies, Inc. GBX rose sharply during Friday's session following upbeat earnings. Greenbrier posted adjusted earnings of 96 cents per share, topping market estimates of 73 cents ...
Here's Why You Should Retain Alexandria ( ARE ) Stock for Now
Alexandria (ARE) is likely to benefit from the solid demand for top-quality life-science assets in key markets. However, a vast development outlay amid high interest rates is concerning.
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference - Cargo Therapeutics ( NASDAQ:CRGX )
SAN MATEO, Calif., Jan. 03, 2024 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. CRGX, a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will participate in the 42nd Annual J.P.
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
SAN MATEO, Calif., Jan. 03, 2024 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. ( NASDAQ: CRGX ) , a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will participate in the 42nd ...
BioSpace Names Most Promising New Biopharma Companies to Watch in 2024
DES MOINES, Iowa, Jan. 3, 2024 /PRNewswire/ -- BioSpace, the leading life sciences news and careers site, has announced its 2024 selections for the industry's most promising up-and-coming companies. The NextGen Class of 2024 list showcases 30 innovative organizations demonstrating exciting ...
Alexandria ( ARE ) Inks Leases at its Campuses Amid Solid Demand
Amid the booming demand for life-science assets, Alexandria (ARE) inks leases with Novo Nordisk and CARGO at its mega campuses in Greater Boston and San Carlos in the San Francisco Bay Area.
Alexandria Real Estate Equities, Inc. Announces Long-Term 99,557 RSF Lease With CARGO Therapeutics for Its New Headquarters and R&D Center at the Alexandria Center for Life Science - San Carlos Mega Campus in the San Francisco Bay Area - Alexandria Real Estate ( NYSE:ARE )
PASADENA, Calif., Dec. 14, 2023 /PRNewswire/ -- Alexandria Real Estate Equities, Inc.
CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results - Cargo Therapeutics ( NASDAQ:CRGX )
SAN MATEO, Calif., Dec. 13, 2023 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. CRGX, a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today reported business updates and its financial results for the third ...
CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results
SAN MATEO, Calif., Dec. 13, 2023 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. ( Nasdaq: CRGX ) , a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today reported business updates and its financial results for ...
CARGO Therapeutics Announces Scientific Advisory Board
SAN MATEO, Calif., Dec. 06, 2023 ( GLOBE NEWSWIRE ) -- CARGO Therapeutics, Inc. ( CRGX ) , a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced the formation of a Scientific Advisory Board ...
Insiders Buying C.H. Robinson Worldwide And 3 Other Stocks - C.H. Robinson Worldwide ( NASDAQ:CHRW ) , Cargo Therapeutics ( NASDAQ:CRGX )
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red Tree Venture Capital as Partner
Former Venture Partner at Versant Ventures and CEO of Inception, Versant's San Diego Company Creation Engine, Brings Red Tree Strong Ties to San Diego Biopharmaceutical Ecosystem
